|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 06 '25 | Option Exercise | 0.00 | 37,166 | 0 | 34,741 | Jan 06 08:35 PM |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 06 '25 | Sale | 14.92 | 21,200 | 316,391 | 14,741 | Jan 06 08:35 PM |
| ZYME | Moore Paul Andrew | Officer | Jan 06 '25 | Proposed Sale | 14.46 | 21,200 | 306,552 | Jan 06 07:43 PM | |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 05 '24 | Option Exercise | 0.00 | 17,166 | 0 | 17,166 | Jan 08 06:01 PM |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 05 '24 | Sale | 10.65 | 7,460 | 79,465 | 9,706 | Jan 08 06:01 PM |
| ZYME | Moore Paul Andrew | Chief Scientific Officer | Jan 08 '24 | Sale | 11.22 | 2,339 | 26,233 | 7,367 | Jan 08 06:01 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite